Deficiency of MBL (≤0.1 μg/mL) was significantly more frequent in patients with serious infections when compared to those with no infection within the follow-up period (p<0.05) [6] in a cohort of 128 patients with hematological malignancies treated by chemotherapy alone or combined with bone marrow transplantation. Here, MBL2 is linked to hematologic disorder.